CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer.
CONCLUSION: As the CEA DNA vaccine displayed encouraging antitumor effects, therefore, we suggest that it can be a potential therapeutic modality for colorectal cancer and is worthy of further investigation.
PMID: 31552832 [PubMed - in process]
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Tags: Iran J Immunol Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | Colorectal Cancer | Immunotherapy | Iran Health | Middle East Health | Vaccines